Solid dispersions: An overview to modify bioavailability of poorly water soluble drugs

International Journal of PharmTech Research

Volumn 1, Issue 4, 2009, Pages 1338-1349

  Tiwari, Ruchi ^a   Tiwari, Gaurav ^a   Srivastava, Birendra ^b   Rai, Awani K ^a  

^a PRANVEER SINGH INSTITUTE OF TECHNOLOGY   (India)

^b JAIPUR NATIONAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CELLULOSE DERIVATIVE; CHLORAMPHENICOL; CORTICOSTEROID; DRUG CARRIER; FELODIPINE; GELUCIRE; GRISEOFULVIN; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; MACROGOL; MACROGOL 400; MACROGOL 6000; NABILONE; NAPROXEN; NICOTINIC ACID; PARACETAMOL; PHENOBARBITAL; POLOXAMER; POLYMER; POLYMETHACRYLIC ACID; POLYSORBATE 80; POLYVINYL ACETATE; POVIDONE; ROSUVASTATIN; SOLVENT; SURFACTANT; TACROLIMUS; UNINDEXED DRUG; WATER;

CRYSTAL STRUCTURE; CRYSTALLIZATION; DISPERSION; DRUG BIOAVAILABILITY; DRUG CLASSIFICATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; EVAPORATION; HYDROPHOBICITY; MACROMOLECULE; MISCIBILITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; SOLID; STORAGE TEMPERATURE; SUPERCRITICAL FLUID; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION;

EID: 77953366143     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Iqbal, Z.; Babar, A.; Muhammad, A. Controlled-release Naproxen using micronized Ethyl Cellulose by wet-granulation and solid dispersion method. Drug Dev. Ind. Pharm. 2002, 28 (2), 129-134.
2. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. Theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995, 12 (3), 413-420.
3. Anguiano-Igea, S.; Otero-Espinar, F. J.; Vilajato, J. L.; Blanco-mendez, J. The properties of solid dispersions of clofibrate in polyethylene glycols. Int. J. Pharm. 1995, 70, 57-66.
4. Serajuddin, A. T. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999, 88, 1058-1066.
5. Craig, D. Q. M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 2002, 231, 131-144.
6. Chiou, W.L.; Riegelman, S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971, 60, 1281-1302.
7. Matsumoto, T.; Zografi, G. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacetate) in relation to indomethacin crystallization. Pharm. Res. 1999, 16, 1722-1728.
8. Van den Mooter, G. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int. J. Pharm. 2006, 316, 1-6.
9. Tanaka, N. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J. Contr. Release. 2005, 108, 386-395.
10. Kimura, T.; Tanaka, N.; Imai, K.; Okimoto, K.; Ueda, S.; Tokunaga, Y.; Ibuki, R.; Higaki, K. Development of novel sustained-release system, disintegration controlled matrix tablet (DCMT) with solid dispersion granules of Nilvadipine (II): In vivo evaluation. J. Control Release. 2006, 112, 51-56.
11. Dangprasirt, P.; Pongwai S. Development of Diclofenac Sodium controlled-release solid dispersion powders and capsules by Freeze drying technique using Ethyl Cellulose and Chitosan as carriers. Drug Dev. Ind. Pharm. 1998, 24 (10), 947-949
12. Lannuccelli, V.; Coppi, G.; Leo, E.; Fontana, F.; Bernabei, M. T. PVP solid dispersions for the controlled-release of Furosemide from a floating multiple-unit system. Drug Dev. Ind. Pharm. 2000, 26 (6), 595-603.
13. Lovrecich, M.; Nobile, F.; Rubessa, F.; Zingone, G. Effect of ageing on the release of Indomethacin from solid dispersions with Eudragit. Int. J. Pharm. 1996, 131, 247-255.
14. Huang, J. Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery: Effect of drug loading on release kinetics. Int. J. Pharm. 2006, 319, 44-54.
15. Tanaka, N. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. J. Contr. Release. 2006, 112, 51-56.
16. Van Drooge, D.J. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int. J. Pharm. 2006, 310, 220-229.
17. Kanig, J.L. Properties of Fused Mannitol in Compressed Tablets. J. Pharm. Sci. 1964, 53, 188-192
18. Chiou, W. L.; Riegelman, S. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J. Pharm. Sci. 1969, 58, 1505-1510.
19. Chiou, W. L.; Riegelman, S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971, 60 (9), 1281-1302.
20. Karavas, E. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Biopharm. 2006, 64, 115-126.
21. Hasegawa, S. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int. J. Pharm. 2005, 302, 103-112.
22. Van den Mooter, G. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 2001, 12, 261-269.
23. Ahuja, N. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur. J. Pharm. Biopharm. 2007, 65, 26-38.
24. Paulaitis, M. M. Solid solubilities in supercritical fluids at elevated pressure. Rev. Chem. Eng. 1983, 1, 179-188.
25. Palakodaty, S.; York, P. Phase behavioural effects on particle formation processes using supercritical fluids. Pharm. Res. 1999, 16, 976-980.
26. Debenedetti, P. G.; Kumar, S. K. The molecular basis of temperature effects in supercritical extraction. Al Chem EJ. 1998, 34, 1211.
27. Dobbs, J. M.; Wong, J. M.; Johnston, K.P. Nonpolar co-solvents for solubility enhancement in 28. supercritical fluid carbpn dioxide. J. chem. Eng. Data. 1986, 37, 303-308.
28. Craig, D. Q. M. Polyethylene glycols and drug release. Drug Dev. Ind. Pharm. 1990, 16, 2501-2527.
29. Gupta, M. K.; Goldman, D.; Bogner, R. H.; Tseng, Y. C. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm Dev Tech. 2001, 6, 563-572
30. Gupta, M. K.; Bogner, R. H.; Goldman, D.; Tsend, Y. C. Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage. Pharm Dev Tech. 2002, 7, 103-112 (Pubitemid 35154420)
31. Gupta, M. K.; Tseng, Y. C.; Goldman, D.; Bogner, R. H. Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharm Res. 2002, 11, 1663-1672 (Pubitemid 35305518)
32. nd edn; Marcel Dekker Inc. Vol.I, 2002, 811-832, 641-647.
33. Serajuddin ATM, Sheen PC, Mufson D, Bernstein DF and Augustine MA (1988). Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water soluble drug from solid dispersions. J. Pharm. Sci., 77: 414-417. (Pubitemid 19080862)
34. Sertsou G, James Butler, Andy Scott, John Hempenstall and Thomas Rades (2002). Factors affecting incorporation of drug into solid solution with HPMCP during solvent change co-precipitation. Int. J. Pharm., 245(1-2): 99-108. (Pubitemid 35299896)
35. Sethia S and Squillante E (2002). Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J. Pharm. Sci., 91(9): 1948-1957. (Pubitemid 36254931)
36. Sethia S and Squillante E (2003). Solid dispersions: revival with greater possibilities and applications in oral drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 20(2-3): 215-247. (Pubitemid 37237280)
37. Sheen PC, Khetarpal VK, Cariola CM and Rowlings CE (1995). Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int. J. Pharm., 118: 221-227.
38. Sheen PC, Kim SI, Petillo JJ and Serajuddin ATM (1991). Bioavailability of a poorly water-soluble drug from tablet and solid dispersion in humans. J. Pharm. Sci. 80: 712-714.
39. Simonelli AP, Mehta SC and Higuchi WI (1969). Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J. Pharm. Sci., 58(5): 538-549.
40. Singh P, Leslie Z. Benet, V. N. Bhatia, J. Keith Guillory and Theodore D. Sokoloski (1966). Effect of inert tablet ingredients on drug absorption. I. Effect of polyethylene glycol 4000 on the intestinal absorption of four barbiturates. J. Pharm. Sci., 55(1): 63-68.
41. Sjokvist E, Nystrom C, Aldén M and Caram-Lelham N (1992). Physicochemical aspects of drug release. XIV. The effects of some ionic and nonionic surfactants on properties of a sparingly soluble drug in solid dispersions. Int. J. Pharm., 79: 123-133.
42. Slade L and Levine H (1991). A food polymer science approach to structureproperty relationships in aqueous food systems: non-equilibrium behavior of carbohydrate-water systems, in Water relationships in food, H. Levine and L. Slade, Editors. Plenum Press: New York, pp.29-101.
43. Subramaniam B, Rajewski RA and Snavely K (1997). Pharmaceutical processing with supercritical carbon dioxide. J. Pharm. Sci., 86(8): 885-890. (Pubitemid 27344044)